Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

Nobel Prize Recipient, Louis Ignarro, on Scientific Committee of "Fondazione Internazionale Menarini"
  • USA - Français
  • Latin America - español
  • USA - Deutsch
  • USA - español
  • USA - English
  • Brazil - Português

Menarini Logo

News provided by

Menarini I.F.R.

25 Oct, 2019, 03:47 IST

Share this article

Share toX

Share this article

Share toX

FLORENCE, Italy, Oct. 24, 2019 /PRNewswire/ -- His discoveries have changed the lives of millions of people. Thanks to his insight, he has won the world's most prestigious scientific honour. Today, his valuable experience will contribute towards bolstering the mission of the "Fondazione Internazionale Menarini" which welcomes the winner of the Nobel prize for Medicine, Louis Ignarro.

Continue Reading
Louis Ignarro
Louis Ignarro

Born in Brooklyn (New York), the son of Italian immigrants, Ignarro discovered his love for chemistry at the age of 8 when he carried out his first experiments with a children's game. This passion never faded and, after a brilliant academic career at the Columbia University in New York and long periods of research in other prestigious American universities, he joined the University of California, Los Angeles (UCLA). It was during this time that he was awarded the Nobel Prize for Medicine and Physiology "for his contribution in discovering the workings of the nitric acid molecule in the cardiovascular system." It is to his studies that we owe the development of medicines commonly used in treating erectile dysfunction and hypertension. Ignarro is one of the founders of the Nitric Oxide Society and is currently Professor of Pharmacology in the Department of Molecular Medical Pharmacology at the UCLA School of Medicine.

Speaking from Los Angeles, Louis Ignarro, had this to say about this exciting collaboration with the Foundation: "Having taught in several American universities, I have always appreciated the work carried out by the Fondazione Internazionale Menarini: their educational activities at congresses and on the internet represent a unique scientific asset. Thanks to this collaboration, I shall continue to contribute to the scientific instruction of researchers, clinicians, students, and young people."

"We are honoured to have Professor Ignarro join our Scientific Committee," commented Lorenzo Melani, Chairman and Scientific Director of the Fondazione Internazionale Menarini. "With the help of his experience, we shall continue to further promote research and understanding in the fields of biology, pharmacology, medicine, economics, and human sciences, which represent the institutional aims of the Fondazione Internazionale Menarini."

For further information on "Fondazione Internazionale Menarini" visit the website https://www.en.fondazione-menarini.it/.

Photo - https://mma.prnewswire.com/media/1017026/Louis_Ignarro.jpg
Logo - https://mma.prnewswire.com/media/1017025/Menarini_Logo.jpg

Related Links

https://www.menarini.it

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.